Peripherally Inserted Central Catheters Market Size & Growth Forecast 2027–2036, By Segments (Product, Lumen, End-use, Applications), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Peripherally Inserted Central Catheters Market size was more than USD 1.64 Billion in 2026 and is set to grow at 10.18% CAGR between 2027 and 2036, reaching USD 4.32 Billion by 2036. The industry revenue for 2027 is calculated at USD 1.78 Billion.

• Base Year Value (2026): USD 1.64 Billion
• CAGR (2027-2036): 10.18%
• Forecast Year Value (2036): USD 4.32 Billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Peripherally Inserted Central Catheters Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held 37.15% in 2025, supported by established hospital infrastructure, widespread intravenous therapy, clinical awareness, and demand for reliable long-term vascular access.
  • Asia Pacific is the fastest-growing region, driven by expanding hospitals, rising healthcare expenditure, advanced procedures, and growing treatment needs requiring extended intravenous therapy.

• Segment Momentum:

  • Power injected PICCs held 48.87% of the market in 2025 because they support both intravenous therapy and contrast-enhanced imaging, reducing repeated catheter placements while providing versatile vascular access across hospitals.
  • Homecare settings are growing the fastest as more patients receive long-term intravenous therapies outside hospitals. Advances in home healthcare and patient monitoring are improving convenience while supporting cost-effective care delivery.

• Market Expansion Drivers:

  • Rising prevalence of chronic diseases increasing demand for long-term intravenous access devices
  • Increasing infectious disease burden driving hospital use of safe vascular access solutions
  • Technological advancements improving catheter safety, durability, and insertion precision in clinical settings

• Leading Market Participants:

  Key players in the peripherally inserted central catheters market include Becton, Dickinson and Company (United States), Teleflex Incorporated (United States), B. Braun Melsungen AG (Germany), ICU Medical, Inc. (United States), Cardinal Health, Inc. (United States), AngioDynamics, Inc. (United States), Terumo Corporation (Japan), Cook Medical LLC (United States), Medtronic plc (Ireland)

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 1.64 Billion
  • 2027 Estimated Market Size: USD 1.78 Billion
  • Projected Market Size: USD 4.32 Billion by 2036
  • Growth Forecasts: 10.18% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Power Injected PICC (Product) | Double (Lumen) | Hospitals (End-use) | Long-Term IV Infusion (Applications)
  • Emerging Opportunity Segment: Neonatal PICC (Product) | Multiple (Lumen) | Homecare Settings (End-use) | Parenteral Nutrition (Applications)

Market Growth Drivers and Industry Trends

Rising prevalence of chronic diseases increasing demand for long-term intravenous access devices

The growing burden of chronic illnesses requiring extended medication and infusion therapies is increasing the need for reliable vascular access solutions across healthcare facilities. Rising prevalence of chronic diseases will drive the peripherally inserted central catheters market growth as patients undergoing long-term treatments rely on these devices for repeated intravenous administration while reducing the need for frequent access procedures. Healthcare providers are increasingly adopting these catheters to support treatment continuity in oncology, critical care, and chronic disease management settings.

Increasing infectious disease burden driving hospital use of safe vascular access solutions

The continued need for effective infection management is encouraging hospitals to prioritize vascular access devices designed to improve patient safety and reduce complications. Increasing infectious disease burden will propel the peripherally inserted central catheters market demand by increasing the use of secure intravenous access solutions for antibiotic therapies, prolonged treatments, and complex care protocols. These devices help clinicians manage extended treatment regimens while supporting improved patient care practices.

Technological advancements improving catheter safety, durability, and insertion precision in clinical settings

Innovation in catheter materials, placement technologies, and procedural tools is enhancing the reliability of vascular access procedures. Technological advancements improving catheter safety, durability, and insertion precision will boost the peripherally inserted central catheters market growth by enabling healthcare professionals to achieve more accurate placement and minimize procedure-related risks. Improved designs are supporting broader clinical adoption by addressing challenges associated with long-term catheter use.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of chronic diseases increasing demand for long-term intravenous access devices	3.3%	High	North America, Europe	High	Near Term
Increasing infectious disease burden driving hospital use of safe vascular access solutions	3.2%	High	Asia Pacific, Latin America	High	Near Term
Technological advancements improving catheter safety, durability, and insertion precision in clinical settings	3.1%	High	North America, Europe	High	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

Holding the largest share of the peripherally inserted central catheters market, North America represented 37.15% of the market in 2026. The region's position is supported by well-established hospital infrastructure, widespread use of intravenous therapies, and increasing demand for reliable vascular access among patients requiring prolonged treatment. Greater adoption of minimally invasive catheterization techniques, strong clinical awareness, and established protocols for managing complex and long-term care needs are contributing to sustained utilization across healthcare facilities.

Asia Pacific is projected to experience the fastest growth in the peripherally inserted central catheters market, supported by expanding hospital networks, rising healthcare expenditure, and increasing access to advanced medical procedures. Growing treatment demand for cancer, infectious diseases, and other conditions requiring extended intravenous therapy is creating opportunities for catheter adoption. Improvements in critical care and oncology infrastructure, along with greater awareness among healthcare professionals regarding vascular access management, are further strengthening regional market development.

No card data available for this language/report.

Segment Leadership and Growth Trends

 

Product Segment Analysis: Power Injected PICC (Largest Segment) vs Neonatal PICC (Fastest-Growing Segment)

The power injected PICC product segment held the largest share of the peripherally inserted central catheters market, accounting for 48.87% in 2026. These catheters are widely utilized because they support both intravenous therapy and contrast-enhanced imaging procedures, allowing healthcare providers to perform multiple clinical functions through a single vascular access device. Their versatility, reduced need for repeated catheter placement, and broad use across hospital settings continue to strengthen their leading market position.

The neonatal PICC product segment is expected to witness the fastest growth. Increasing demand for specialized vascular access devices designed for premature and critically ill newborns is supporting wider adoption in neonatal care. Advances in neonatal intensive care practices, improved survival rates among preterm infants, and growing emphasis on minimizing vascular complications are expected to accelerate demand for neonatal PICCs.

Lumen Segment Analysis: Double (Largest Segment) vs Multiple (Fastest-Growing Segment)

The double lumen segment accounted for the largest share of 51.52% in 2026. Double lumen catheters are widely preferred because they enable simultaneous administration of multiple medications, fluids, or nutritional therapies while reducing the need for additional vascular access procedures. Their balance between clinical flexibility and patient comfort has made them a standard choice across diverse healthcare settings.

The multiple lumen segment is projected to record the fastest growth in the peripherally inserted central catheters market. Increasing treatment complexity, rising use of combination therapies, and growing demand for efficient critical care management are driving the adoption of catheters capable of supporting several infusion pathways simultaneously. Their ability to improve workflow efficiency and accommodate advanced treatment protocols is expected to support continued market expansion.

End-use Segment Analysis: Hospitals (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)

The hospitals end-use segment captured the largest share of 41.8% in 2026. Hospitals remain the primary users of peripherally inserted central catheters due to the high volume of inpatient procedures requiring long-term intravenous therapy, chemotherapy, antimicrobial treatment, and critical care support. The availability of specialized healthcare professionals and advanced clinical infrastructure continues to reinforce the segment's dominant position.

The homecare settings end-use segment is anticipated to experience the fastest growth in the peripherally inserted central catheters market. Increasing preference for receiving long-term intravenous therapies outside hospital environments, combined with advances in home healthcare services and patient monitoring, is encouraging broader adoption. The growing focus on improving patient convenience, reducing hospital stays, and supporting cost-effective care delivery is expected to drive sustained growth in this segment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Power Injected PICC, Conventional PICC, Neonatal PICC	Power Injected PICC	Neonatal PICC
Lumen	Single, Double, Multiple	Double	Multiple
End-use	Hospitals, Ambulatory Surgical Centers, Homecare Settings, Others	Hospitals	Homecare Settings
Applications	Chemotherapy, Long-term IV Infusion, Parenteral Nutrition, Blood Transfusion, Others	Long-Term IV Infusion	Parenteral Nutrition

Competitive Landscape and Market Positioning

Key companies in the peripherally inserted central catheters market:

1. Becton Dickinson and Company (United States)
2. Teleflex Incorporated (United States)
3. B. Braun Melsungen AG (Germany)
4. ICU Medical, Inc. (United States)
5. Cardinal Health, Inc. (United States)
6. AngioDynamics, Inc. (United States)
7. Terumo Corporation (Japan)
8. Cook Medical LLC (United States)
9. Medtronic plc (Ireland)

Clinical outcomes and procedural efficiency are increasingly defining how suppliers compete in the peripherally inserted central catheters market. Manufacturers are placing greater emphasis on catheter designs that simplify placement, reduce procedural complexity, and support infection prevention across a wide range of care settings. As healthcare providers seek standardized vascular access solutions with lower maintenance demands, competitive differentiation is expanding beyond product performance to include clinician support, compatibility with imaging and navigation technologies, and the ability to address diverse patient requirements through broader product portfolios.

Industry Development/News

Company Name	Date	Key Development
Teleflex Incorporated	Jul-25	Teleflex completed the EUR 760 million acquisition of BIOTRONIK's vascular intervention business, expanding its catheter portfolio with vascular intervention technologies including drug-coated balloons and stents. The acquisition strengthens the company's interventional access and catheter franchise, enhancing its competitive position across the vascular access market.
BD	Feb-25	BD announced plans to separate its Biosciences and Diagnostic Solutions business to sharpen its strategic focus on its core medical technology portfolio, including vascular access products such as peripherally inserted central catheters, supporting greater operational focus and long-term portfolio development.
Teleflex Incorporated	May-23	Teleflex launched the Arrow VPS Rhythm DLX Device and NaviCurve Stylet in the United States to support peripherally inserted central catheter placement. The introduction expanded the company's vascular access portfolio by enhancing catheter navigation and placement capabilities, strengthening its offering for clinicians performing PICC procedures.
B. Braun Medical Inc.	Sep-22	B. Braun Medical acquired the Clik-FIX catheter securement device portfolio from Starboard Medical, strengthening its vascular access product offering with enhanced catheter securement solutions. The acquisition expands the company's portfolio and reinforces its position in catheter management and associated clinical applications.